<DOC>
	<DOCNO>NCT01206946</DOCNO>
	<brief_summary>The hypothesis study administration antenatal steroid woman high risk preterm birth 34 week gestation would reduce risk respiratory complication , specifically Respiratory Distress Syndrome ( RDS ) Transient Tachypnea Newborn ( TTN ) late preterm baby .</brief_summary>
	<brief_title>Efficacy Antenatal Steroids Reducing Respiratory Morbidities Late Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Transient Tachypnea Newborn</mesh_term>
	<mesh_term>Tachypnea</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Women 34 0/7 36 6/7 week gestation High risk preterm birth Multiple birth Fetal congenital malformation A course steroid within 2 week randomization Multiple course steroid Chorioamnionitis Non reassure fetal heart rate Obstetrical indication delivery Active bleeding Pregnancy relate hypertensive disorder Uncontrolled diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Respiratory distress</keyword>
	<keyword>Antenatal steroid</keyword>
	<keyword>late preterm</keyword>
</DOC>